Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-17-000827
Filing Date
2017-09-07
Accepted
2017-09-07 17:13:25
Documents
1
Period of Report
2017-09-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ferrari_form4sep72017.html 4  
1 OWNERSHIP DOCUMENT ferrari_form4sep72017.xml 4 3829
  Complete submission text file 0000905718-17-000827.txt   5273
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
FERRARI STEFANO (Reporting) CIK: 0001588237 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 171074467